Solana Latest Updates: VanEck's Collaboration on a Staked Solana ETF Reflects Growing Institutional Trust in Blockchain's Prospects
- VanEck partners with SOL Strategies for staking in its new Solana ETF (VSOL), enhancing institutional blockchain integration. - SOL Strategies' ISO-certified validators secure $437M+ in assets, chosen for operational expertise and institutional focus. - VSOL offers staking rewards with fee waivers until $1B AUM, reflecting growing demand for Solana-based funds like Bitwise's BSOL. - VanEck's $5.2B digital asset portfolio expands with VSOL, though staking risks and regulatory uncertainties remain for inve
VanEck, a prominent asset management firm, has chosen
Based in Toronto, SOL Strategies specializes in Solana infrastructure and operates ISO 27001 and SOC 2-certified validators, securing more than CAD$610 million ($437 million) in staked assets. The company pointed out that its
VanEck’s
The debut of the ETF comes amid recent
SOL Strategies, which rebranded from Cypherpunk Holdings in 2024, holds 524,000 SOL in its reserves and is listed on both the Canadian Securities Exchange (HODL) and Nasdaq (STKE). Despite recent drops in its share prices—HODL declined 5.85% to CAD$3.38, while
Nonetheless, the partnership is not without risks. Staking SOL involves locking assets during activation and deactivation, and validators may incur penalties for downtime or improper conduct. Regulatory changes could also affect staking operations or the ETF’s framework. VanEck
---
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
ALGS drops 12.49% over 7 days amid optimism for HBV and MASH treatments
- Aligos Therapeutics (ALGS) saw a 12.49% 7-day stock decline despite positive HBV/MASH trial data. - Pevifoscorvir showed superior HBV DNA suppression and safety, with Phase II trials ongoing for 2026-2027 data. - ALG-009 demonstrated metabolic benefits for MASH, positioning Aligos as a key player in liver disease innovation. - Recent 23,600-share equity grants to new hires aim to strengthen R&D capabilities and operational growth.

The COAI Token Fraud: An Urgent Warning for Cryptocurrency Investors
- COAI token's 88% collapse in 2025 exposed DeFi vulnerabilities, driven by C3.ai leadership turmoil, $116.8M losses, and a class-action lawsuit. - Regulatory ambiguity (CLARITY Act) and technical flaws like Balancer's $116M exploit highlight systemic risks in decentralized finance. - Global DeFi exploits cost $2B+ in 2025, with Singapore reporting doubled fraud claims involving credential theft and impersonation. - Experts urge rigorous due diligence: audit smart contracts, analyze tokenomics, verify team

Cboe Introduces Nation’s First Regulated 10-Year Crypto Futures to Address Institutional Needs
- Cboe launches first U.S.-regulated 10-year Bitcoin/Ether Continuous Futures (PBT/PET) on Dec 15, 2025, offering institutional investors long-term crypto exposure without offshore reliance. - Products feature daily cash adjustments to spot prices, eliminating rollovers, and are centrally cleared via CFTC-regulated Cboe Clear U.S., enabling cross-margining with existing FBT/FET futures. - 23×5 trading schedule and Funding Amount mechanism align with market conditions, addressing operational friction while
PEPE Consolidates Near $0.055 as Support and Resistance Levels Shape a Tight Trading Range
